Dino A. Rossi

CIK: 0001209059

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)10 (62.5%)

Position reduction

Option Exercises (M)1 (6.3%)

Derivative conversions

Awards (A)3 (18.8%)

Compensation grants

Other (G, F, J, C, D, …)2 (12.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

KRYS

Krystal Biotech, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (16 total)

KRYS
Krystal Biotech, Inc.
Sep 14, 2026
Award(A)
Stock Option (Right to Buy)
Direct
1.2K shares-
KRYS
Krystal Biotech, Inc.
Sep 14, 2026
Award(A)
Restricted Stock Units
Direct
471 shares-
KRYS
Krystal Biotech, Inc.
Aug 14, 2026
Sale(S)
Direct
341 shares at avg. $325.60$111K
KRYS
Krystal Biotech, Inc.
Aug 14, 2026
Sale(S)
Direct
2.3K shares at avg. $326.60$747K
KRYS
Krystal Biotech, Inc.
Aug 14, 2026
Sale(S)
Direct
5.2K shares at avg. $327.39$1.7M
KRYS
Krystal Biotech, Inc.
Aug 14, 2026
Sale(S)
Direct
1.7K shares at avg. $328.52$554K
KRYS
Krystal Biotech, Inc.
Aug 14, 2026
Sale(S)
Direct
7.4K shares at avg. $329.60$2.4M
KRYS
Krystal Biotech, Inc.
Aug 14, 2026
Gift(G)
Direct
3.7K shares-
KRYS
Krystal Biotech, Inc.
Aug 14, 2026
Sale(S)
Direct
4.9K shares at avg. $330.36$1.6M
KRYS
Krystal Biotech, Inc.
Aug 14, 2026
Sale(S)
Direct
3.1K shares at avg. $331.43$1.0M
KRYS
Krystal Biotech, Inc.
Aug 14, 2026
Sale(S)
Direct
40 shares at avg. $333.23$13K
KRYS
Krystal Biotech, Inc.
Feb 19, 2026
Sale(S)
Direct
8.1K shares at avg. $260.49$2.1M
KRYS
Krystal Biotech, Inc.
Feb 19, 2026
Exercise(M)
Direct
19K shares at avg. $8.79$167K
KRYS
Krystal Biotech, Inc.
Feb 19, 2026
Sale(S)
Direct
10.8K shares at avg. $262.10$2.8M
KRYS
Krystal Biotech, Inc.
Jun 30, 2025
Award(A)
Stock Option (Right to Buy)
Direct
5K shares-
KRYS
Krystal Biotech, Inc.
Sep 13, 2024
Gift(G)
Direct
5K shares-

		Type	Shares	Price		Ownership
Sep 14, 2026	KRYS Krystal Biotech, Inc.	Award(A) Stock Option (Right to Buy)	1,187	-	-	Direct
Sep 14, 2026	KRYS Krystal Biotech, Inc.	Award(A) Restricted Stock Units	471	-	-	Direct
Aug 14, 2026	KRYS Krystal Biotech, Inc.	Sale(S)	341	$325.60	$111,029	Direct
Aug 14, 2026	KRYS Krystal Biotech, Inc.	Sale(S)	2,287	$326.60	$746,941	Direct
Aug 14, 2026	KRYS Krystal Biotech, Inc.	Sale(S)	5,226	$327.39	$1,710,961	Direct
Aug 14, 2026	KRYS Krystal Biotech, Inc.	Sale(S)	1,687	$328.52	$554,205	Direct
Aug 14, 2026	KRYS Krystal Biotech, Inc.	Sale(S)	7,428	$329.60	$2,448,280	Direct
Aug 14, 2026	KRYS Krystal Biotech, Inc.	Gift(G)	3,691	-	$0	Direct
Aug 14, 2026	KRYS Krystal Biotech, Inc.	Sale(S)	4,896	$330.36	$1,617,422	Direct
Aug 14, 2026	KRYS Krystal Biotech, Inc.	Sale(S)	3,095	$331.43	$1,025,786	Direct
Aug 14, 2026	KRYS Krystal Biotech, Inc.	Sale(S)	40	$333.23	$13,329	Direct
Feb 19, 2026	KRYS Krystal Biotech, Inc.	Sale(S)	8,116	$260.49	$2,114,103	Direct
Feb 19, 2026	KRYS Krystal Biotech, Inc.	Exercise(M)	18,950	$8.79	$166,570	Direct
Feb 19, 2026	KRYS Krystal Biotech, Inc.	Sale(S)	10,834	$262.10	$2,839,591	Direct
Jun 30, 2025	KRYS Krystal Biotech, Inc.	Award(A) Stock Option (Right to Buy)	5,000	-	-	Direct
Sep 13, 2024	KRYS Krystal Biotech, Inc.	Gift(G)	5,000	-	$0	Direct

1-16 of 16 transactions

About ROSSI DINO A

ROSSI DINO A (SEC CIK 0001209059) files insider reports with the SEC as Director of Krystal Biotech, Inc. (KRYS).

Signal8 holds 5 ownership filings by ROSSI DINO A, all Form 4s, filed between Sep 13, 2024 and Sep 16, 2026. Those filings report 16 transactions, from Sep 13, 2024 to Sep 14, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on ROSSI DINO A's filings is in PITTSBURGH, PA.

Recent filings by ROSSI DINO A

Sep 14, 2026: Grants or awards of KRYS derivative securities (2 lines, Form 4, code A).
Aug 14, 2026: Open-market sales of KRYS shares (5 lines, Form 4, code S).
Aug 14, 2026: Gift of KRYS shares (Form 4, code G).
Aug 14, 2026: Open-market sales of KRYS shares (3 lines, Form 4, code S).
Feb 19, 2026: Open-market sale of KRYS shares (Form 4, code S).

Other insiders filing for Krystal Biotech, Inc. (KRYS)

Sutherland Everett Rand, Director
Mazzacco Catherine, Director
Mason Christopher, Director
JANNEY DANIEL, Director
Gangolli Julian S, Director
Krishnan Suma, President, R&D

How to read Form 4 transaction codes